# SHIRE HUMAN GENETIC THERAPIES, INC.

FEI: 3009340644
Status: Active
Establishment types: Develop Specifications But Do Not Manufacture At This Facility
Owner/operator: Takeda Pharmaceuticals U.S.A., Inc. (#10051446)

Address: 300 SHIRE WAY, Lexington, MA, US



## Products

Total registered: 1
Top product codes: LHI
Regulation §: 880.5440

Proprietary names: Baxject II Needleless Transfer Device

## Source

- openFDA: https://api.fda.gov/device/registrationlisting.json?search=registration.fei_number:%223009340644%22
- FDA Registration Lookup: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm?lid=3009340644